Overview
NUTX market data
Price History
NUTX price chart
Valuation & Profitability
- P/E (TTM)
- 13.50 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $10.48 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.58 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 6.3% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 11.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $77.21 – $204.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.3B · P/B 1.18 · P/S 1.48.
Company News
Lake Street Maintains Buy on Nutex Health, Raises Price Target to $310Benzinga · Aug 11, 2026, 6:55 PM
Nutex Health shares are trading higher after the company reported better-than-expected Q2 EPS results.Benzinga · Aug 7, 2026, 4:07 PM
Nutex Health Q2 EPS $9.38 Beats $4.95 Estimate, Sales $210.752M Miss $215.031M EstimateBenzinga · Aug 6, 2026, 8:48 PM
8-K filing — Nutex Health Inc. (NUTX)SEC EDGAR · Jul 21, 2026, 9:22 PM
B. Riley Securities Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $290Benzinga · Jun 26, 2026, 3:40 PM
Lake Street Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $235Benzinga · Jun 2, 2026, 3:40 PM